How is the efficacy of patient selection criteria of KEYNOTE 564 for adjuvant pembrolizumab after curative surgical treatment of clear cell renal cell carcinoma with intermediate to high risk of recurrence? A real-life data analysis from single institutional experience

ERDEM S., Tantekin A., Ozervarli F., ERGÜL R. B., Pazir Y., HÜRDOĞAN Ö., ...More

ANNALS OF ONCOLOGY, vol.36, 2025 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Abstract
  • Volume: 36
  • Publication Date: 2025
  • Doi Number: 10.1016/j.annonc.2025.08.3271
  • Journal Name: ANNALS OF ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Istanbul University Affiliated: Yes